【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Cardiovascular Surgery Devices Overview 17
3 Products under Development 19
3.1 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 19
3.2 Cardiovascular Surgery Devices – Pipeline Products by Segment 20
3.3 Cardiovascular Surgery Devices – Pipeline Products by Territory 21
3.4 Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 23
3.5 Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 24
3.6 Cardiovascular Surgery Devices – Ongoing Clinical Trials 25
4 Cardiovascular Surgery Devices – Pipeline Products under Development by Companies 26
4.1 Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development 26
4.2 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 30
5 Cardiovascular Surgery Devices Companies and Product Overview 34
5.1 3S BioMedical, Inc. Company Overview 34
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 AblaCor Medical Corporation Company Overview 35
5.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Advanced Catheter Therapies, Inc. Company Overview 36
5.3.1 Advanced Catheter Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 AdvanSource Biomaterials Corporation Company Overview 38
5.4.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 AFreeze GmbH Company Overview 42
5.5.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Anethon (Inactive) Company Overview 47
5.6.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47
5.7 AngioDynamics, Inc. Company Overview 48
5.7.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Apaxis Medical, Inc. Company Overview 51
5.8.1 Apaxis Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.9 APK Advanced Medical Technologies, Inc. Company Overview 55
5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 Arterion AB Company Overview 56
5.10.1 Arterion AB Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 AtriCure, Inc. Company Overview 57
5.11.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Axcelon Biopolymers Corp. Company Overview 61
5.12.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Beth Israel Deaconess Medical Center, Inc. Company Overview 62
5.13.1 Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Bioretec Ltd. Company Overview 64
5.14.1 Bioretec Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.15 Boston University Company Overview 65
5.15.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 65
5.16 CardioPolymers, Inc. Company Overview 67
5.16.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 CardioPrecision Ltd Company Overview 68
5.17.1 CardioPrecision Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 CardioScout, LLC Company Overview 69
5.18.1 CardioScout, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 CellProthera Company Overview 70
5.19.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Children’s Hospital Boston Company Overview 72
5.20.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 72
5.21 Circulatory Technology Inc. Company Overview 74
5.21.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.22 Cleveland Clinic Hospital Company Overview 75
5.22.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 75
5.23 Corazon Technologies, Inc. Company Overview 77
5.23.1 Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.24 CorMatrix Cardiovascular, Inc. Company Overview 78
5.24.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.25 Coromedic Ltd. Company Overview 81
5.25.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.26 CPSI Biotech Company Overview 83
5.26.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Cytograft Tissue Engineering, Inc. Company Overview 84
5.27.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Design Mentor, Inc. Company Overview 88
5.28.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.29 Edwards Lifesciences Corporation Company Overview 89
5.29.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.30 Elana bv Company Overview 91
5.30.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 91
5.31 Emory University Company Overview 92
5.31.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 92
5.32 Endogene Ltd Company Overview 94
5.32.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.33 EpiEP, Inc. Company Overview 97
5.33.1 EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.34 European Medical Contract Manufacturing B.V. Company Overview 98
5.34.1 European Medical Contract Manufacturing B.V. Pipeline Products & Ongoing Clinical Trials Overview 98
5.35 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Company Overview 99
5.35.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Pipeline Products & Ongoing Clinical Trials Overview 99
5.36 Graft-Loc Inc. Company Overview 100
5.36.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.37 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 101
5.37.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
5.38 Harpoon Medical, Inc. Company Overview 103
5.38.1 Harpoon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.39 HeartLander Surgical, Inc. Company Overview 106
5.39.1 HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.40 Helical Solutions, Inc. Company Overview 107
5.40.1 Helical Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.41 Hocor Cardiovascular Technologies, LLC Company Overview 108
5.41.1 Hocor Cardiovascular Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 iiTech BV Company Overview 109
5.42.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Kardium Inc. Company Overview 112
5.43.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Kips Bay Medical, Inc. Company Overview 116
5.44.1 Kips Bay Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.45 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 118
5.45.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118
5.46 LivaNova PLC Company Overview 119
5.46.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.47 LuxCath, LLC Company Overview 126
5.47.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 126
5.48 Magenta Medical Inc Company Overview 127
5.48.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.49 Mayo Clinic. Company Overview 128
5.49.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 MedArray Inc. Company Overview 129
5.50.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.51 Medrobotics Corporation Company Overview 132
5.51.1 Medrobotics Corporation Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Medtronic plc Company Overview 134
5.52.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 134
5.53 Michigan Critical Care Consultants, Inc. Company Overview 136
5.53.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.54 MicroPort Scientific Corporation Company Overview 137
5.54.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neograft Technologies, Inc. Company Overview 139
5.55.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 Nipro Corporation Company Overview 142
5.56.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 142
5.57 Northwestern University Company Overview 145
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 NovelMed Therapeutics, Inc. Company Overview 148
5.58.1 NovelMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.59 Novogate Medical Ltd. Company Overview 149
5.59.1 Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 149
5.60 NuPulse Inc Company Overview 150
5.60.1 NuPulse Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.61 NuVascular Technologies Inc Company Overview 151
5.61.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 151
5.62 Prekubator TTO Company Overview 152
5.62.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 152
5.63 Protego Medical Pty Ltd Company Overview 153
5.63.1 Protego Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 153
5.64 Rafael Medical Technologies, Inc. Company Overview 154
5.64.1 Rafael Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.65 Replication Medical, Inc. Company Overview 155
5.65.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
5.66 Revivicor, Inc. Company Overview 157
5.66.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 SeamVad Ltd. Company Overview 158
5.67.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.68 SentreHEART, Inc. Company Overview 160
5.68.1 SentreHEART, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.69 Sorin S.p.A. (Inactive) Company Overview 163
5.69.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163
5.70 Southern Research Institute Company Overview 166
5.70.1 Southern Research Institute Pipeline Products & Ongoing Clinical Trials Overview 166
5.71 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 167
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 167
5.72 St. Jude Medical, Inc. Company Overview 171
5.72.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.73 Stanford University Company Overview 173
5.73.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 173
5.74 Synovis Life Technologies, Inc. Company Overview 175
5.74.1 Synovis Life Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.75 Tengion, Inc. (Inactive) Company Overview 176
5.75.1 Tengion, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176
5.76 The Johns Hopkins University Company Overview 178
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 178
5.77 The Spectranetics Corporation Company Overview 180
5.77.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 180
5.78 The University of Utah Company Overview 182
5.78.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 182
5.79 Theracardia Company Overview 184
5.79.1 Theracardia Pipeline Products & Ongoing Clinical Trials Overview 184
5.80 Thermedical, Inc. Company Overview 185
5.80.1 Thermedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.81 Tissue Regeneration Technologies, LLC Company Overview 187
5.81.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 187
5.82 Trivitron Healthcare Pvt Ltd. Company Overview 189
5.82.1 Trivitron Healthcare Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 189
5.83 Tufts Medical Center Company Overview 190
5.83.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 190
5.84 Universite de Montreal Company Overview 191
5.84.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 191
5.85 University College London Company Overview 193
5.85.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 University of Arizona Company Overview 194
5.86.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 University of California, Los Angeles Company Overview 196
5.87.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 University of Nebraska Company Overview 199
5.88.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 199
5.89 University of Pittsburgh Company Overview 200
5.89.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 200
5.90 University of Strathclyde Company Overview 202
5.90.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 202
5.91 Vanderbilt University Company Overview 203
5.91.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 203
5.92 Veniti, Inc. Company Overview 205
5.92.1 Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.93 Ventrica, Inc. Company Overview 206
5.93.1 Ventrica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
5.94 VytronUS, Inc. Company Overview 207
5.94.1 VytronUS, Inc. Pipeline Products & Ongoing Clinical Trials Overview 207
5.95 W-Z BIOTECH, LLC Company Overview 208
5.95.1 W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 208
6 Cardiovascular Surgery Devices- Recent Developments 210
7 Appendix 339
7.1 Methodology 339
7.2 About GlobalData 341
7.3 Contact Us 342
7.4 Disclaimer 342
【レポート販売概要】
■ タイトル：世界の心血管手術機器開発動向：医療機器パイプライン分析2015■ 英文：Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0141EPD
■ 調査対象地域：グローバル
- 六方晶窒化硼素（h-BN）粉末の世界市場予測（～2021年）The global hexagonal-boron nitride (h-BN) powder market is estimated to reach USD 821.0 Million by 2021, at a CAGR of 5.1% from 2016 to 2021. H-BN powder has high thermal stability and excellent electrical insulation properties, and H-BN powder products offer high performance and durability. These factors drive the market for the h-BN powder globally. H-BN powder products find usage in application …
- 世界の送配電（Transmission and Distribution）装備市場：Global T&D Equipment Market 2014-2018TechNavio's analysts forecast the Global T&D Equipment market to grow at a CAGR of 9.45 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in demand of T&D equipment from developing nations. The Global T&D Equipment market has also been witnessing the increasing outsourcing of manufacturing activities to the developing countries. However, t …
- 下垂体ACTH過剰分泌(クッシング病)：グローバル臨床試験レビュー（2014年上半期）Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Pituitary ACTH Hypersecretion (Cushing’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- モバイルデータモニタリング（MDM）の世界市場About MDM MDM software are used to review or monitor performance of mobile devices in terms of data speed, usage, signal strength, and data transfer. They simplify tracking of data being transferred to other users. MDM solution is equipped with an easy user-interface that enables easy access to details about data upload or download speeds. Further, the solution also provides graphical representati …
- 世界のサプライチェーン分析：タブレットPC市場After four years of rapid growth, development of the worldwide tablet market slowed down in 2014, with mature markets in the United States and Western Europe reaching a saturation point. Leading brands including Apple, Samsung, Amazon, and Google have faced stagnant or even declining sales. Affected by affordable branded tablets and large-sized mobile phones, shipments of entry-level white-box tab …
- 防水テープの世界市場予測（～2022年）The global waterproof tapes market is estimated at USD 9.96 Billion in 2017 and is projected to reach USD 13.95 Billion by 2022, at a CAGR of 6.97% from 2017 to 2022. The demand for waterproof tapes has been increasing in end-use industries, such as building & construction, automotive, electrical & electronics, healthcare, packaging, and others. Several manufacturers of waterproof tapes are undert …
- スクーク（イスラム債券）の世界市場2016-2020About Sukuk Sukuk comes from the word "sakk" which is considered an investment certificate that follows Islamic financing principles. The sukuk helps to facilitate trade transactions as this serves as a promissory note among merchants. The issuer of the sukuk sells the certificate to an investor group. This investor group rents the certificate back to the issuer at a predetermined fee. The issuer …
- 尿路カテーテルの世界市場：間欠カテーテル、フォーリーカテーテル、外部カテーテルAbout Urinary Catheters Urinary catheters are hollow, partially flexible tubes that help collect urine from the bladder. These devices are attached to a drainage bag that collect the urine. They are available in the market in the forms of rubber, plastic, silicone, or latex. The catheter tube is attached to a drainage bag that holds the collected urine. These catheters can be used permanently or t …
- 債務担保証券（CDO）の世界市場2016-2020About the Collateralized Debt Obligation (CDO) Market CDO refer to the securities that are packaged as one unit and serves as collateral for investors. The packaged assets comprise the corporate debt, mortgages, credit card, or automotive loans that are otherwise individual fixed income assets, which are sold on the secondary market. CDO allows banks and large corporations to sell off their debt, …
- 石油ガス生産用海中アンビリカル、ライザー、およびフローライン（SURF）市場予測（2014-2024）The global Subsea Umbilicals, Risers & Flowlines (SURF) Market has great potential for growth globally. Key regions such as West Africa, South America, the Gulf of Mexico and the North Sea are attracting a lot of interest with regards to the growth of their subsea market. Due to SURF’s pivotal role within subsea production and processing systems, the SURF market has many opportunities within these …
- 自動車サスペンション装置の世界市場The automotive suspension system market is anticipated to see a considerable growth in countries such as China, India, Mexico, and Spain. Due to the stringent emission regulations and fuel efficiency standards enforced by the different legislative bodies across the globe, therefore it has forced all the OEMS to look for altered solutions to achieve the same. Thus, the semi-active/active systems we …
- 4G and WiMAX for the Smart Grid: Enabling Access, Applications and AffordabilityAny smart grid is a telecommunications network for the utility and the communities it serves. 4G technologies provide any power utility with the most cost effective technology in monitoring the grid from power production to power consumption. Not only will a 4G smart grid read meters, they will also provide a range of cost saving services to the utility and the community as a whole. Mind Commerce' …
- 鉱物綿の世界市場：ガラス綿、ロックウール（岩綿）The mineral wool market can be segmented into four major regions, which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). Ceramic fiber finds usage in different types of insulation applications such as Fire protection, Thermal insulation, Acoustic insulations, and other applications. The mineral wool market is a growing market, the mineral wool market in the Asia-Pacific region …
- 自動車アフターマーケットE小売の世界市場2020-2024Global Automotive Aftermarket E-Retailing Market 2020-2024 Technavio has been monitoring the global automotive aftermarket e-retailing market and it is poised to grow by USD 41.86 bn during 2020-2024, progressing at a CAGR of 19% during the forecast period. Our reports on automotive aftermarket e-retailing market provides a holistic analysis, market size and forecast, trends, growth drivers, and c …
- SONAR（水中音波探知機）の世界市場：ハル搭載ソナー、ソノブイ、戦術曳航ソナー、可変深度ソナー、携帯式ソナーThe SONAR systems and technology market is estimated to be at $3.41 billion in 2014 and is expected to register a CAGR of 6.22% to reach $4.90 billion by 2020. The report provides key statistics for the forecast period. The research report provides in-depth insights with regards to the SONAR systems and technology market. The report contains profiles of leading players involved in this market such …
